Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1197
| Despition | Dopamine Transporter Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1096 | Synthetic Nanodisc Human CXCR4 Protein (AC1096) | 10 µg | inquiry |
| ACPP-1075 | GABA B Receptor 2 Blocking Peptide (AC1075) | 250 µg | inquiry |
| ACPP-1622 | Human DLK1 Protein (AC1622) | 2 µg | inquiry |
| ACPP-1146 | Recombinant Human Artemin Protein (Fc Tag) (AC1146) | 50 µg | inquiry |
| ACPP-1307 | NPY2R Blocking Peptide (AC1307) | 250 µg | inquiry |
| ACPP-1039 | Recombinant Human FGFR4 Protein (6×His Tag) (AC1039) | 50 µg | inquiry |
| ACPP-1555 | Human TGFBI Protein, 182 a.a. (AC1555) | 10 µg | inquiry |
| ACPP-1780 | Human DYRK1A Protein (AC1780) | 5 µg | inquiry |
| ACPP-1812 | Human IMPA1 Protein (AC1812) | 5 µg | inquiry |
| ACPP-1470 | Human CLTA Protein (AC1470) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.